Fig. 6

The effect of ANXA2/AKT/eNOS signaling pathway on cellular senescence of PDLCs under high glucose conditions. PDLCs were transfected with pcDNA3.1-ANXA2 or its empty vector controls, followed by treatment with high glucose, MK2206(10µM)(AKT inhibitor) and L-NAME (100µM)(eNOS inhibitor) (A) The SA-β-gal staining of PDLCs. (B) Semi-quantitative analysis of SA-β-gal staining was performed by an Image J Analyzer. (C,D) The mRNAs of p21, p16 were evaluated by qRT-PCR. All data are presented as the means ± SEM from three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001. CTRL: Control; 40G: 40mM glucose; 40G-A: 40mM glucose + ANXA2 overexpression; 40G-A-MK: 40mM glucose + ANXA2 overexpression + MK2206(AKT inhibitor); 40G-A-LN: 40mM glucose + ANXA2 overexpression + L-NAME (eNOS inhibitor).